Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia

Journal of Veterinary Internal Medicine

Volumn 20, Issue 3, 2006, Pages 682-686

  Weiss, Douglas J ^a   Brazzell, Jennifer L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Flow cytometry; P selectin; Platelet function; Thrombosis

Indexed keywords

DIAGNOSTIC AGENT; PADGEM PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; BLOOD CLOTTING TEST; CASE CONTROL STUDY; CYTOLOGY; DOG; DOG DISEASE; DRUG EFFECT; EVALUATION; FEMALE; FLOW CYTOMETRY; MALE; METABOLISM; PEDIGREE; PREDICTION AND FORECASTING; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; MALE; P-SELECTIN; PEDIGREE; PLATELET ACTIVATION; PREDICTIVE VALUE OF TESTS; TETRADECANOYLPHORBOL ACETATE; THROMBOEMBOLISM;

CANIS FAMILIARIS;

EID: 33646855119     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[682:DOAPID]2.0.CO;2     Document Type: Article

References (27)

1. Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 dogs. J Vet Intern Med 2002;16:504-509.
2. Klag AR, Giger U, Shofer FS. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990). J Am Vet Med Assoc 1993;202:783-788.
3. Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999). J Am Vet Med Assoc 2001;218:543-546.
4. Burgess K, Moore A, Rand W, et al. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. J Vet Intern Med 2000;14:456-462.
5. Prufer A. Autoimmune-mediated anaemia in the dog: A retrospective study of 41 cases. Kleintierpraxis 1995;40:649-656.
6. Mischke R. Haemostatic disorders as a complication of autoimmunohaemolytic anaemia in dogs. Deutsche Tier Wocherschrift 1998;105:13-16.
7. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001;37:220-227.
8. Bunch SE, Metcalf MR, Crane SW, et al. Idiopathic pleural effusion and pulmonary thromboembolism in a dog with autoimmune hemolytic anemia. J Am Vet Med Assoc 1989;195:1748-1753.
9. Klein MK, Dow SW, Rodney AW, et al. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: Ten cases (1982-1987). J Am Vet Med Assoc 1989;195:246-250.
10. Lifton SJ. Managing immune-mediated hemolytic anemia in dogs. Vet Med 1999;94:532-545.
11. Thomas JS, Rogers KS. Platelet aggregation and adenosine triphosphate secretion in dogs with untreated multicentric lymphoma. J Vet Intern Med 1999;13:319-322.
12. McNiel EA, Ogilvie GK, Fettman MJ, et al. Platelet hyperfunction in dogs with malignancies. J Vet Intern Med 1997;11:178-182.
13. Boudreaux MK, Dillon AR, Spano JS. Enhanced platelet reactivity in heartworm-infected dogs. Am J Vet Res 1989;50:1544-1547.
14. Green RA, Russo EA, Greene RT, et al. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J Am Vet Med Assoc 1985;186:485-488.
15. Moritz A, Walcheck BK, Weiss DJ. Flow cytometric detection of activated platelets in the dog. Vet Clin Pathol 2003;32:6-12.
16. Macey MG, Carty E, Chapman ES, et al. Use of mean platelet component to measure platelet activation in the ADVIA 120 hematology system. Cytometry 1999;8:1-7.
17. Zelmanovic D, Hetherington EJ. Automated analysis of feline platelets in whole blood including platelet count, mean platelet volume and activation state. Vet Clin Pathol 1998;27:2-9.
18. Moritz A, Walcheck BK, Weiss DJ. Evaluation of flow cytometric and automated methods for detection of activated platelets in dogs with inflammatory disease. Am J Vet Res 2005;66:325-329.
19. Stenberg DE, McEver RP, Shuman MA, et al. A platelet membrane glycoprotein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101:880-886.
20. Wilkerson MJ, Shuman W. Alterations in normal canine platelets during storage in EDTA anticoagulated blood. Vet Clin Pathol 2001;30:107-113.
21. Levine SP. Secreted platelet proteins as markers for pathologic disorders. In: Phillips DR, Shuman MA, eds. Biochemistry of Platelets. Orlando, FL. Academic Press; 1986:378-389.
22. McManus PM, Craig LE. Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999). J Am Vet Med Assoc 2001;218:1308-1313.
23. Moritz A, Deye J, Walcheck B, Weiss DJ. Effects of racing activity on platelet and neutrophil activation in Siberian Husky dogs. Am J Vet Res 2003;64:855-859.
24. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002;30:S313-317.
25. Salat A, Bodingbauer G, Boehm D, et al. Changes of platelet surface antigens in patients suffering from abdominal septic shock. Thromb Res 1999;95:289-294.
26. Hirsh J, Glynn MF, Mustard JF. The effects of platelet age on platelet adherence to collagen. J Clin Invest 1968;47:466-473.
27. Shulman NR. Evidence that the spleen will change the youngest and hemostatically most effective platelets. Am J Physiol 1968;81:302-311.